Your Privacy and our use of cookiesUkraine - UK Pharmaceutical Industry ResponseABPI 2021 Code of PracticeMembershipClaire Machin, ABPI Executive Director of International Policy and UK Competitiveness said: “This is a positive step for research into finding long term solutions for AMR. “Alongside today’s announcement, England has also been leading the way as the first country to implement a pilot scheme for incentivising the development of new treatments using an innovative payment arrangement, but the UK acting on it's own cannot combat AMR. 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB